<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Medicine Man Technologies Inc — News on 6ix</title>
<link>https://6ix.com/company/medicine-man-technologies-inc</link>
<description>Latest news and press releases for Medicine Man Technologies Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Tue, 24 Mar 2026 11:00:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/medicine-man-technologies-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835c0ba78dffbe2df1189c2.webp</url>
<title>Medicine Man Technologies Inc</title>
<link>https://6ix.com/company/medicine-man-technologies-inc</link>
</image>
<item>
<title>Vireo Growth Inc. Announces Closing of Acquisition of Assets of Schwazze</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/vireo-growth-inc-announces-closing-of-acquisition-of-assets-of-schwazze-1</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/vireo-growth-inc-announces-closing-of-acquisition-of-assets-of-schwazze-1</guid>
<pubDate>Tue, 24 Mar 2026 11:00:00 GMT</pubDate>
<description>– Vireo acquires 24 dispensaries in Colorado, 21 dispensaries in New Mexico and 1 manufacturing facility in each of Colorado and New Mexico at an assumed share price of $0.661 – Justin Dye to become Chairman of Vireo’s Colorado and New Mexico business – Forrest Hoffmaster announced as CEO of Vireo’s Colorado and New Mexico business MINNEAPOLIS, March 24, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo” or the “Company”) (CSE: VREO; OTCQX: VREOF) today announced the closing of its previously d</description>
</item>
<item>
<title>Vireo Growth Inc. to Acquire Additional Outstanding Senior Secured Convertible Notes of Schwazze</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/vireo-growth-inc-to-acquire-additional-outstanding-senior-secured-convertible-notes-of-schwazze-1</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/vireo-growth-inc-to-acquire-additional-outstanding-senior-secured-convertible-notes-of-schwazze-1</guid>
<pubDate>Fri, 19 Dec 2025 23:10:00 GMT</pubDate>
<description>MINNEAPOLIS, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”) today announced that it plans to acquire additional outstanding senior secured convertible notes (the “Notes”) of Medicine Man Technologies Inc. (dba “Schwazze”) from third-party noteholders. Total outstanding principal plus accrued interest of the acquired Notes is approximately $2.6 million, but the Notes will be acquired at a substantial discount to par value for tot</description>
</item>
<item>
<title>Schwazze Reaches Agreement to Restructure its Balance Sheet and Portfolio of Assets</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-reaches-agreement-to-restructure-its-balance-sheet-and-portfolio-of-assets</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-reaches-agreement-to-restructure-its-balance-sheet-and-portfolio-of-assets</guid>
<pubDate>Tue, 14 Oct 2025 12:30:00 GMT</pubDate>
<description>Schwazze Reaches Agreement to Restructure its Balance Sheet and Portfolio of Assets.</description>
</item>
<item>
<title>Vireo Growth Inc. Enters into Definitive Agreements to Acquire Outstanding Senior Secured Convertible Notes of Schwazze</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/vireo-growth-inc-enters-into-definitive-agreements-to-acquire-outstanding-senior-secured-convertible-notes-of-schwazze-1</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/vireo-growth-inc-enters-into-definitive-agreements-to-acquire-outstanding-senior-secured-convertible-notes-of-schwazze-1</guid>
<pubDate>Thu, 02 Oct 2025 23:10:00 GMT</pubDate>
<description>– Transaction reflects continuation of Vireo’s M&A strategy and is expected to close later this month –MINNEAPOLIS, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. ("Vireo" or the "Company") (CSE: VREO; OTCQX: VREOF) today announced that it has entered into definitive agreements to acquire approximately 86% of the outstanding senior secured convertible notes (the “Notes”) of public U.S. multi-state cannabis operator, Medicine Man Technologies Inc. (dba “Schwazze”) from third-party noteholder</description>
</item>
<item>
<title>Schwazze Provides Update on Delayed Filings</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-provides-update-on-delayed-filings</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-provides-update-on-delayed-filings</guid>
<pubDate>Wed, 04 Dec 2024 21:05:24 GMT</pubDate>
<description>Schwazze Provides Update on Delayed Filings.</description>
</item>
<item>
<title>Schwazze Announces Preliminary Third Quarter 2024 Financial Results</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-preliminary-third-quarter-2024-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-preliminary-third-quarter-2024-financial-results</guid>
<pubDate>Thu, 07 Nov 2024 21:05:54 GMT</pubDate>
<description>Schwazze Announces Preliminary Third Quarter 2024 Financial Results.</description>
</item>
<item>
<title>Schwazze Announces Second Quarter 2024 Financial Results</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-second-quarter-2024-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-second-quarter-2024-financial-results</guid>
<pubDate>Tue, 13 Aug 2024 20:08:17 GMT</pubDate>
<description>Schwazze Announces Second Quarter 2024 Financial Results.</description>
</item>
<item>
<title>Schwazze Sets Second Quarter 2024 Conference Call for August 13, 2024 at 5:00 p.m. ET</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-sets-second-quarter-2024-conference-call-for-august-13-2024-at-500-pm-et</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-sets-second-quarter-2024-conference-call-for-august-13-2024-at-500-pm-et</guid>
<pubDate>Tue, 30 Jul 2024 12:30:17 GMT</pubDate>
<description>Schwazze Sets Second Quarter 2024 Conference Call for August 13, 2024 at 5:00 p.m. ET.</description>
</item>
<item>
<title>Schwazze Announces Restructuring of February 2025 Debt Obligations</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-restructuring-of-february-2025-debt-obligations</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-restructuring-of-february-2025-debt-obligations</guid>
<pubDate>Thu, 11 Jul 2024 20:30:23 GMT</pubDate>
<description>Schwazze Announces Restructuring of February 2025 Debt Obligations.</description>
</item>
<item>
<title>Schwazze Announces Transition to OTC Expert Market and Provides Update on Delayed Filing</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-transition-to-otc-expert-market-and-provides-update-on-delayed-filing</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-transition-to-otc-expert-market-and-provides-update-on-delayed-filing</guid>
<pubDate>Mon, 01 Jul 2024 20:30:11 GMT</pubDate>
<description>Schwazze Announces Transition to OTC Expert Market and Provides Update on Delayed Filing.</description>
</item>
<item>
<title>Schwazze Announces Grand Opening of its 35th New Mexico Dispensary in Bernalillo</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-grand-opening-of-its-35th-new-mexico-dispensary-in-bernalillo</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-grand-opening-of-its-35th-new-mexico-dispensary-in-bernalillo</guid>
<pubDate>Fri, 07 Jun 2024 20:30:11 GMT</pubDate>
<description>Schwazze Announces Grand Opening of its 35th New Mexico Dispensary in Bernalillo.</description>
</item>
<item>
<title>Schwazze Announces First Quarter 2024 Financial Results</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-first-quarter-2024-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-first-quarter-2024-financial-results</guid>
<pubDate>Wed, 15 May 2024 20:07:17 GMT</pubDate>
<description>Schwazze Announces First Quarter 2024 Financial Results.</description>
</item>
<item>
<title>Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-sets-first-quarter-2024-conference-call-for-may-15-2024-at-500-pm-et</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-sets-first-quarter-2024-conference-call-for-may-15-2024-at-500-pm-et</guid>
<pubDate>Mon, 29 Apr 2024 20:31:36 GMT</pubDate>
<description>Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET.</description>
</item>
<item>
<title>Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-fourth-quarter-and-full-year-2023-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-fourth-quarter-and-full-year-2023-financial-results</guid>
<pubDate>Wed, 27 Mar 2024 20:06:32 GMT</pubDate>
<description>Schwazze Announces Fourth Quarter and Full Year 2023 Financial Results.</description>
</item>
<item>
<title>Schwazze Sets Fourth Quarter and Full Year 2023 Conference Call for March 27, 2024 at 5:00 p.m. ET</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-sets-fourth-quarter-and-full-year-2023-conference-call-for-march-27-2024-at-500-pm-et</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-sets-fourth-quarter-and-full-year-2023-conference-call-for-march-27-2024-at-500-pm-et</guid>
<pubDate>Tue, 12 Mar 2024 20:31:18 GMT</pubDate>
<description>Schwazze Sets Fourth Quarter and Full Year 2023 Conference Call for March 27, 2024 at 5:00 p.m. ET.</description>
</item>
<item>
<title>Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-appoints-forrest-hoffmaster-as-interim-chief-executive-officer</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-appoints-forrest-hoffmaster-as-interim-chief-executive-officer</guid>
<pubDate>Fri, 23 Feb 2024 12:30:46 GMT</pubDate>
<description>Schwazze Appoints Forrest Hoffmaster as Interim Chief Executive Officer.</description>
</item>
<item>
<title>Schwazze Announces Third Quarter 2023 Financial Results</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-third-quarter-2023-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-third-quarter-2023-financial-results</guid>
<pubDate>Tue, 14 Nov 2023 21:06:54 GMT</pubDate>
<description>Schwazze Announces Third Quarter 2023 Financial Results.</description>
</item>
<item>
<title>Schwazze Sets Third Quarter 2023 Conference Call for November 14, 2023 at 5:00 p.m. ET</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-sets-third-quarter-2023-conference-call-for-november-14-2023-at-500-pm-et</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-sets-third-quarter-2023-conference-call-for-november-14-2023-at-500-pm-et</guid>
<pubDate>Mon, 30 Oct 2023 12:31:44 GMT</pubDate>
<description>Schwazze Sets Third Quarter 2023 Conference Call for November 14, 2023 at 5:00 p.m. ET.</description>
</item>
<item>
<title>Schwazze Announces Launch of Standing Akimbo Hotspot, a New Store Within A Store Concept in Fort Collins</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-launch-of-standing-akimbo-hotspot-a-new-store-within-a-store-concept-in-fort-collins</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-launch-of-standing-akimbo-hotspot-a-new-store-within-a-store-concept-in-fort-collins</guid>
<pubDate>Fri, 20 Oct 2023 20:56:22 GMT</pubDate>
<description>Schwazze Announces Launch of Standing Akimbo Hotspot, a New Store Within A Store Concept in Fort Collins.</description>
</item>
<item>
<title>Schwazze Announces Second Quarter 2023 Financial Results</title>
<link>https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-second-quarter-2023-financial-results</link>
<guid isPermaLink="true">https://6ix.com/company/medicine-man-technologies-inc/news/schwazze-announces-second-quarter-2023-financial-results</guid>
<pubDate>Wed, 09 Aug 2023 20:31:04 GMT</pubDate>
<description>Schwazze Announces Second Quarter 2023 Financial Results.</description>
</item>
</channel>
</rss>